HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giovanni Cassani Selected Research

ST2146biot

4/2006Low and high tenascin-expressing tumors are efficiently targeted by ST2146 monoclonal antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giovanni Cassani Research Topics

Disease

1Carcinoma (Carcinomatosis)
04/2006
1Glioblastoma (Glioblastoma Multiforme)
04/2006
1Neoplasms (Cancer)
04/2006

Drug/Important Bio-Agent (IBA)

1ST2146biotIBA
04/2006
1Monoclonal AntibodiesIBA
04/2006
1TenascinIBA
04/2006

Therapy/Procedure

1Radioimmunotherapy
04/2006